Healthpeak Properties, Inc. (DOC)
NYSE: DOC · Real-Time Price · USD
18.48
+0.21 (1.18%)
Jul 10, 2025, 10:23 AM - Market open
Healthpeak Properties Stock Forecast
Stock Price Forecast
The 10 analysts that cover Healthpeak Properties stock have a consensus rating of "Buy" and an average price target of $23.1, which forecasts a 25.03% increase in the stock price over the next year. The lowest target is $20 and the highest is $28.
Price Target: $23.1 (+25.03%)
Analyst Consensus: Buy
* Price targets were last updated on Jun 2, 2025.
Analyst Ratings
The average analyst rating for Healthpeak Properties stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 6 | 6 | 6 | 6 | 6 | 6 |
Hold | 3 | 3 | 3 | 3 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 11 | 11 | 11 | 11 | 10 | 10 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wells Fargo | Wells Fargo | Hold Maintains $22 → $20 | Hold | Maintains | $22 → $20 | +8.25% | Jun 2, 2025 |
Scotiabank | Scotiabank | Buy Maintains $23 → $21 | Buy | Maintains | $23 → $21 | +13.67% | May 12, 2025 |
Argus Research | Argus Research | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +35.32% | Apr 29, 2025 |
Baird | Baird | Buy Maintains $24 → $22 | Buy | Maintains | $24 → $22 | +19.08% | Apr 29, 2025 |
Evercore ISI Group | Evercore ISI Group | Buy Maintains $23 → $21 | Buy | Maintains | $23 → $21 | +13.67% | Apr 28, 2025 |
Financial Forecast
Revenue This Year
2.81B
from 2.70B
Increased by 3.91%
Revenue Next Year
2.92B
from 2.81B
Increased by 3.88%
EPS This Year
0.25
from 0.36
Decreased by -31.15%
EPS Next Year
0.31
from 0.25
Increased by 24.55%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 3.0B | 3.2B | 3.3B |
Avg | 2.8B | 2.9B | 3.0B |
Low | 2.6B | 2.7B | 2.8B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 10.9% | 13.3% | 13.2% |
Avg | 3.9% | 3.9% | 3.5% |
Low | -2.4% | -4.5% | -4.4% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 0.33 | 0.39 | 0.42 |
Avg | 0.25 | 0.31 | 0.28 |
Low | 0.19 | 0.21 | 0.20 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | -9.2% | 57.4% | 36.6% |
Avg | -31.2% | 24.5% | -8.7% |
Low | -48.1% | -16.6% | -36.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.